FIS
FCPM III Services Portfolio holdings
AUM
$369M
This Quarter Return
-2.91%
1 Year Return
-29.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$582M
AUM Growth
+$582M
(-14%)
Cap. Flow
-$63M
Cap. Flow
% of AUM
-10.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$4.91M |
Top Sells
| 1 |
Dyne Therapeutics
DYN
|
$67.9M |
Sector Composition
| 1 | Healthcare | 98.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Dyne Therapeutics
DYN
$1.92B
| $214M | 36.73% |
5,954,069
-1,891,295
| -24% | -$67.9M |
|
2
NewAmsterdam Pharma
NAMS
$2.71B
| $196M | 33.73% |
11,831,461
| – | – |
|
3
enGene Holdings
ENGN
$236M
| $57.3M | 9.84% |
8,677,951
| – | – |
|
4
Replimune Group
REPL
$422M
| $53.3M | 9.16% |
4,866,449
| – | – |
|
|
BCYC
5
Bicycle Therapeutics
BCYC
$511M
| $53M | 9.09% |
2,339,961
+217,069
| +10% | +$4.91M |
|
|
6
enGene Holdings Inc. Warrants
ENGNW
$7.08M
| $6.04M | 1.04% |
2,878,148
| – | – |
|
|
ACHL
7
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $2.44M | 0.42% |
2,390,050
| – | – |
|